Mark E. Chan
FDA investigator
Appears on 2 documents from 2015, mostly at sites in California. Most often cites design controls (21 CFR 820.30(a)).
- 2
- Documents on file
- 12.0
- Observations per 483
- 2015
- First seen
- 2015
- Most recent
What they cite most
From 24 observations- 21 CFR 820.30(a)Design controls6
- 21 CFR 820.198(a)Complaint files3
- 21 CFR 820.100(a)Corrective and preventive action2
- 21 CFR 820.25(a)Personnel2
- 21 CFR 820.50Purchasing controls2
- 21 CFR 820.120Device labeling1
Activity by year
2015: 2
Where
California 2
Often inspects with
Is Mark E. Chan coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2015-07-06 | 483 Agilent Technologies, IncJul 6, 2015 · Santa Clara, California | Santa Clara, California | 2 | |
| 2015-05-12 | 483 Helio USA Inc.May 12, 2015 · San Jose, California | San Jose, California | 22 |
About this profile
What does Mark E. Chan inspect?
Mark E. Chan appears on 2 documents on file covering 2 sites, mostly in California.
What do they cite most often?
21 CFR 820.30(a) (design controls), followed by 21 CFR 820.198(a) and 21 CFR 820.100(a).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Mark E. Chan is dated Jul 6, 2015.